Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 12, 2021

SELL
$72.25 - $168.95 $6.07 Million - $14.2 Million
-84,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $3.77 Million - $5.36 Million
30,000 Added 55.56%
84,000 $14.3 Million
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $381,360 - $517,020
3,000 Added 5.88%
54,000 $7.58 Million
Q2 2020

Feb 12, 2021

BUY
$93.0 - $171.7 $4.7 Million - $8.67 Million
50,490 Added 9900.0%
51,000 $8.18 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $4.6 Million - $8.5 Million
-49,490 Reduced 98.98%
510 $2.73 Million
Q1 2020

Feb 12, 2021

BUY
$82.38 - $131.64 $4.08 Million - $6.52 Million
49,500 Added 9900.0%
50,000 $4.89 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $2.43 Million - $3.88 Million
-29,500 Reduced 98.33%
500 $908,000
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $1.07 Million - $1.41 Million
30,000
30,000 $33.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.